Related references
Note: Only part of the references are listed.A survey of medical cannabis use during perimenopause and postmenopause
M. Kathryn Dahlgren et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2022)
Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020-2022)
Jose Diogo R. Souza et al.
PHARMACEUTICS (2022)
Serum Markers of Bone Turnover Following Controlled Administration of Two Medical Cannabis Products in Healthy Adults
Justyna Kulpa et al.
CANNABIS AND CANNABINOID RESEARCH (2022)
Declining serum bone turnover markers are associated with the short-term positive change of lumbar spine bone mineral density in postmenopausal women
Shengli Zhao et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2022)
Critical Role of Estrogens on Bone Homeostasis in Both Male and Female: From Physiology to Medical Implications
Emmanuelle Noirrit-Esclassan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials
Edward Chesney et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Cannabidiol induces osteoblast differentiation via angiopoietin1 and p38 MAPK
Mi-Ae Kang et al.
ENVIRONMENTAL TOXICOLOGY (2020)
Cannabidiol-loaded microspheres incorporated into osteoconductive scaffold enhance mesenchymal stem cell recruitment and regeneration of critical-sized bone defects
Amir Kamali et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2019)
A Novel, Tumor-Induced Osteoclastogenesis Pathway Insensitive to Denosumab but Interfered by Cannabidiol
Maiko Tsuchiya et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Symptoms of menopause - global prevalence, physiology and implications
Patrizia Monteleone et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Cannabidiol administration reduces sublesional cancellous bone loss in rats with severe spinal cord injury
Dehao Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability
P. Szulc et al.
OSTEOPOROSIS INTERNATIONAL (2017)
An Atmospheric Pressure Chemical Ionization MS/MS Assay Using Online Extraction for the Analysis of 11 Cannabinoids and Metabolites in Human Plasma and Urine
Jelena Klawitter et al.
THERAPEUTIC DRUG MONITORING (2017)
Osteoporosis treatment: recent developments and ongoing challenges
Sundeep Khosla et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2017)
Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study
K. E. Naylor et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Cannabidiol, a Major Non-Psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts
Natalya M. Kogan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Moderate-severely bothersome vasomotor symptoms are associated with lowered psychological general wellbeing in women at midlife
Pragya Gartoulla et al.
MATURITAS (2015)
Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells
Rinaldo Florencio-Silva et al.
BIOMED RESEARCH INTERNATIONAL (2015)
A Meta-Analysis of Reference Markers of Bone Turnover for Prediction of Fracture
Helena Johansson et al.
CALCIFIED TISSUE INTERNATIONAL (2014)
The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine
Nicole C. Wright et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Age-related reference intervals for bone turnover markers from an Australian reference population
N. Jenkins et al.
BONE (2013)
Bone turnover markers: use in osteoporosis
Kim Naylor et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats
Marcelo H. Napimoga et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo
Lauren S. Whyte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Biomarkers of bone health and osteoporosis risk
Richard Eastell et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2008)
Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women
NH Bjarnason et al.
BONE (2000)
Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy
S Christgau et al.
BONE (2000)
Share Paper
